Online Program Home
My Program

Abstract Details

Activity Number: 160
Type: Topic Contributed
Date/Time: Monday, August 1, 2016 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #319978
Title: Does the Direction of Scores Matter in Clinical Trials?
Author(s): Wanjie Sun* and Stella Grosser and Yi Tsong
Companies: FDA and FDA/CDER and FDA/CDER
Keywords: Superiority ; non-inferiority ; equivalence ; ratio of means ; difference of means ; power
Abstract:

When defining a scoring system for a continuous outcome during study design, a question of interest is, does the direction of scores (the larger or the smaller value, the better effect) matter in testing for superiority, non-inferiority(NI), or equivalence? In other words, will this change the power of the test? For continuous data, ratio of means and difference of means are often used as a measure to evaluate whether the test mean is superior to, NI, or equivalent to the reference mean by zero (for superiority) or by a certain margin (for NI or equivalence). Therefore, does the measure (difference or ratio) play a role in addressing this question? Our conclusions: 1) Direction of scores does not change the power in testing for superiority, NI or bioequivalence when difference of means is used as the measure; 2) However, direction of scores does change the power when ratio of means is used, especially for a NI and equivalence test. Caution should be used.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association